LAWRENCEVILLE, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it has ...

Applicants who want to apply for the courses can fill TS EAMCET application form 2025 at the application link on eapcet.tgche.ac.in.